CYSTIC FIBROSIS FOUND THERAPEUTICS INC has a total of 20 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Brazil and Mexico. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TELIGENE LTD, GALLEON PHARMACEUTICALS INC and SILVERSTONE PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Brazil | 2 | |
#3 | Mexico | 2 | |
#4 | Canada | 1 | |
#5 | Chile | 1 | |
#6 | China | 1 | |
#7 | Colombia | 1 | |
#8 | Costa Rica | 1 | |
#9 | Dominican Republic | 1 | |
#10 | Ecuador | 1 | |
#11 | Israel | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Peru | 1 | |
#14 | Philippines | 1 | |
#15 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Thorarensen Atli | 13 |
#2 | Strohbach Joseph Walter | 12 |
#3 | Denny Rajiah Aldrin | 12 |
#4 | Efremov Ivan Viktorovich | 12 |
#5 | Mathias John Paul | 12 |
#6 | Zapf Christoph Wolfgang | 12 |
#7 | Limburg David Christopher | 12 |
#8 | Elbaum Daniel | 11 |
#9 | Gavrin Lori Krim | 9 |
#10 | John Paul Mathias | 5 |
Publication | Filing date | Title |
---|---|---|
MX2019007135A | Bycyclic heteroaryl derivatives as cftr potentiators. | |
CA3044050A1 | Pyrrolopyrimidines as cftr potentiators |